These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 2055992

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Metabolism of metyrapone. 2-Chromatographic and mass spectral properties of the N-oxides of metyrapone and metyrapol.
    Damani LA, Crooks PA, Cowan DA.
    Biomed Mass Spectrom; 1981 Jun; 8(6):270-7. PubMed ID: 7260343
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Simultaneous analysis of 2-methoxyphenylmetyrapone and its seven potential metabolites by high-performance liquid chromatography.
    Damani LA, Tsai MC, Lin G, Mitterhauser M, Zolle I.
    J Chromatogr B Biomed Sci Appl; 1997 Dec 19; 704(1-2):315-23. PubMed ID: 9518165
    [Abstract] [Full Text] [Related]

  • 6. Determination of metyrapone and the enantiomers of its chiral metabolite metyrapol in human plasma and urine using coupled achiral-chiral liquid chromatography.
    Chiarotto JA, Wainer IW.
    J Chromatogr B Biomed Appl; 1995 Mar 10; 665(1):147-54. PubMed ID: 7795785
    [Abstract] [Full Text] [Related]

  • 7. Alteration of the inhibitory effect of metyrapone by reduction to metyrapol during the metabolism of methacetin in vivo in mice.
    Maser E, Legrum W.
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Nov 10; 331(2-3):283-9. PubMed ID: 3937061
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Stereoselective reductive metabolism of metyrapone and inhibitory activity of metyrapone metabolites, metyrapol enantiomers, on steroid 11 beta-hydroxylase in the rat.
    Nagamine S, Horisaka E, Fukuyama Y, Maetani K, Matsuzawa R, Iwakawa S, Asada S.
    Biol Pharm Bull; 1997 Feb 10; 20(2):188-92. PubMed ID: 9057984
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Urinary metabolic profile in rat of 1-(2-methoxyphenyl)-2-methyl-2-(3-pyridyl)-1-propanone: a potential radioligand for functional diagnosis of adrenal pathology.
    Damani LA, Mitterhauser M, Lin G, Ho YP, Zolle I.
    Xenobiotica; 1996 Feb 10; 26(2):211-19. PubMed ID: 8868004
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. High-performance liquid chromatographic determination of nicotinamide and its metabolites in human and murine plasma and urine.
    Stratford MR, Dennis MF.
    J Chromatogr; 1992 Nov 06; 582(1-2):145-51. PubMed ID: 1491034
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [(3)H]metyrapol and 4-[(131)i]iodometomidate label overlapping, but not identical, binding sites on rat adrenal membranes.
    Berger ML, Hammerschmidt F, Qian R, Hahner S, Schirbel A, Stichelberger M, Schibli R, Yu J, Arion VB, Woschek A, Öhler E, Zolle IM.
    Mol Pharm; 2013 Mar 04; 10(3):1119-30. PubMed ID: 23343186
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.